A Provider of High-Performance Enzyme Reagents and POCT Detection Solutions

A Provider of High-Performance Enzyme Reagents and POCT Detection Solutions

Shenzhen EZassay Biotechnology is a national high-tech enterprise focused on the development and production of high-performance enzyme reagents and core raw materials for molecular diagnostics. Building on this foundation, we provide POCT detection platforms and integrated solutions that support needs ranging from scientific research to product development. The company participates in the development of industry standards related to pathogen detection, continues to promote standardized industry practices, and has passed ISO 9001 quality management system certification to ensure stable products and high service standards.

10+

Years of R&D Experience

100+

Products Translated

6+

Core Tech Platforms

What We Do

Our team has deep experience in the in vitro diagnostics field, with extensive expertise in product development and translation. We have completed the development and application of multiple molecular and immunoassay products, participated in the formulation of pathogen detection group standards, and established a complete system covering R&D, production, and sales. Through ISO 9001 quality management system certification, we ensure product stability and controllable quality.

01

Protein Expression and Purification

Focused on the development and preparation of key enzymes and functional proteins, we build a core raw-material system that supports both research and large-scale production while ensuring product performance and supply stability.

02

Isothermal Amplification Technology

A core technology for molecular POCT applications, enabling rapid amplification and detection while balancing sample handling, ease of operation, reaction efficiency, and result stability.

03

CRISPR Detection Technology

Built on CRISPR molecular recognition mechanisms and combined with isothermal amplification, this technology significantly improves detection specificity and supports readouts such as fluorescence and lateral flow.

04

Rapid SNP Detection Technology

Based on isothermal amplification systems, this approach enables rapid SNP detection without sequencing, offering high sensitivity and detection of mutation frequencies as low as 1‰ (1/1000), suitable for low-frequency mutation analysis.

05

ELISA Technology

A classic protein biomarker detection system continuously optimized around sensitivity, specificity, and stability to meet diverse needs in both research and application scenarios.

06

Single-Molecule Immunodetection Platform

Combining CRISPR and immunodetection technologies, this platform enables signal amplification and single-molecule-level detection, improving sensitivity to the fg/mL range and supporting trace biomarker analysis such as Alzheimer's disease-related markers.

Core Team

Founded by professors and PhD professionals from the University of Hong Kong, the team is dedicated to providing more stable and efficient products for institutions and partners.

Dr. Teng Li

Dr. Teng Li

CEO

PhD from the Li Ka Shing Faculty of Medicine at the University of Hong Kong and recognized as a high-level overseas talent in Shenzhen. He has more than 10 years of experience in IVD product R&D, with rich expertise in technology translation and product development.

Dr. Youqiang Song

Dr. Youqiang Song

Chief Scientist

Tenured Professor at the School of Pharmacy, Shenzhen University of Advanced Technology. Former Principal Lecturer and Tenure-Track Associate Professor at the University of Hong Kong. Recognized as a high-level talent in Shenzhen and Guangdong and as a national high-end foreign expert, with more than 20 years of experience in neurogenetics, molecular biology, and bioinformatics.

Dr. Jie Shen

Dr. Jie Shen

Head of Scientific Research

PhD from the Li Ka Shing Faculty of Medicine at the University of Hong Kong, recognized as a high-level overseas talent in Shenzhen and a Futian district talent. He has long been engaged in polymer chemistry, biomaterials, and cell biology research, with extensive scientific experience.

Dr. Yan Peng

Dr. Yan Peng

Head of Clinical Affairs

PhD from the Li Ka Shing Faculty of Medicine at the University of Hong Kong. She received systematic clinical training at Guangzhou General Hospital of Guangzhou Military Command and the First Affiliated Hospital of the PLA General Hospital, with a solid clinical foundation and rich research experience.

Yonghui Wu, M.S.

Yonghui Wu, M.S.

R&D Engineer

Master's degree from Zhongkai University of Agriculture and Engineering. Former research assistant at North Carolina State University and the University of Tennessee, with a solid foundation in molecular biology and product development experience.

Related Publications Using EZassay Kits

EZassay kits have supported multiple high-impact publications, including papers in Nature.

Total Publications: 25Highest IF: 45.8Featured Journals: Nature / Sci Adv / Nat Commun
  1. Lu XY, et al. Feeding induces cholesterol biosynthesis via the mTORC1-USP20-HMGCR axis. Nature. 2020 Nov 11. Impact factor: 45.8
  2. Zhang Y et al. Detection of biological loads in sewage using the automated robot-driven photoelectrochemical biosensing platform. Exploration (Beijing). 2024 Mar 14. Impact factor: 22.5
  3. Ma X., Cao J., Zhou Z. et al. N6-methyladenosine modification-mediated mRNA metabolism is essential for human pancreatic lineage specification and islet organogenesis. Nat Commun. 13, 4148 (2022). Impact factor: 15.7
  4. Wang Y., et al. METTL3 is essential for postnatal development of brown adipose tissue and energy expenditure in mice. Nat Commun. 11, 1648 (2020). Impact factor: 15.7
  5. Weng, L., et al. Surplus fatty acid synthesis increases oxidative stress in adipocytes and induces lipodystrophy. Nat Commun. 15, 133 (2024). Impact factor: 15.7
  6. Li Z,et al. Adipose tissue-derived PRXL2A suppresses hepatic lipogenesis in a study with male mice. Nat Commun. 2025 Jul 16;16(1):6567. Impact factor: 15.7
  7. Chen, Y., Pang, et al. March5-mediated Trim28 degradation preserves islet β-cell function in mice. Nat Commun. 16, 7073 (2025). Impact factor: 15.7
  8. Wang, J., et al. Regulating cleavage activity and enabling microRNA detection with split sgRNA in Cas12b. Nat Commun. 16, 6392 (2025). Impact factor: 15.7
  9. Huang W, et al. Expanding Cas12a Activity Control with an RNA G-Quadruplex at the 5' end of CRISPR RNA. Adv Sci (Weinh). 2025 Feb. Impact factor: 14.3
  10. Zhang Y, et al. Gut Commensal Barnesiella Intestinihominis Ameliorates Hyperglycemia and Liver Metabolic Disorders. Adv Sci (Weinh). 2025 Feb;12(8):e2411181. Impact factor: 14.3

RPA Primer and CRISPR gRNA Online Design Tools

We provide online design tools for RPA primers/probes and Cas12a crRNA, available directly on the EZassay website without installing software.

The tools support rapid sequence analysis and solution generation, helping improve molecular assay development efficiency.

Design Tools

CRISPR Guide RNA Design

Supports Cas12a (Cpf1) parameter configuration and sequence input for online crRNA design.

Use Now

Design Tools

RPA Primer & Probe Design

Designed for RPA workflows, supporting FASTA input and key parameter settings for fast result generation.

Use Now

Trusted by Researchers and Industry Professionals

Supporting innovation and technology transfer through collaborations with universities, hospitals, research institutes, and industry partners.

Beijing Gan & Lee Pharmaceuticals
Junke Zhengyuan (Beijing) Pharmaceutical Research
Jiangsu Province Hospital
Anhui Medical University
Hunan Normal University
Wenzhou Medical University
Wuhan University
Central South University
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Zhejiang University School of Medicine
Tianjin Medical University General Hospital
Tongji Hospital of Wuhan
The Second Xiangya Hospital
Nanjing Drum Tower Hospital
Shanxi Medical University
CAS Key Laboratory of Natural Products Chemistry
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Xuzhou Medical University
Xiamen University
Southwest University
Nanjing Medical University
Peking University
Fudan University
Peking Union Medical College
Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Harbin Institute of Technology
Biotechnology Research Institute, Chinese Academy of Agricultural Sciences

Intellectual Property

01

Patent No. ZL 2020 1 0302411.1

A recombinant RecA* protein and its expression method and application

02

Patent No. ZL 2021 1 373186.5

Primers, probes, kit, application, and method for detecting Ureaplasma urealyticum

03

Patent No. ZL 2024 1 0384155.3

Recombinant collagen mussel adhesive protein and its expression method and application

04

Patent No. ZL 2025 1 0148746.5

Intelligent molecular diagnostic and analysis method, device, equipment, and storage medium

05

Patent No. ZL 2024 2 0920863.X

Reagent detection assembly

06

Patent No. ZL 2021 2 0486235.1

Device for nucleic acid detection using isothermal amplification technology

07

Patent No. ZL 2024 2 0512040.3

A tube mixing device for preparing mussel adhesive protein

08

Patent No. ZL 2021 2 0459140.0

A rapid DNA extraction kit for pleural effusion samples

09

Patent No. ZL 2021 2 0485897.7

A DNA purification kit for biological samples

10

Patent No. ZL 2021 2 0641806.4

A detection kit for diabetes biomarkers

11

Patent No. ZL 2021 2 0641812.X

An insulin assay kit that eliminates interference from insulin autoantibodies

12

Patent No. ZL 2021 2 0458861.X

A puncture-tube device for DNA amplification detection systems

13

Patent No. ZL 2024 2 1652728.8

A PCR tube and a quantitative fluorescence PCR instrument

14

Patent No. ZL 2019 2 0237315.6

An integrated portable rapid DNA detection instrument

15

Patent No. ZL 2019 2 0739370.5

A finger sleeve for promoting hand tendon injury recovery and functional exercise

16

Patent No. ZL 2024 2 1574032.8

A pathogen detection device for aquatic animals

17

Patent No. ZL 2024 2 1574031.3

A kit for rapidly extracting DNA from urine samples

18

Patent No. ZL 2024 2 1358876.9

A pet disease detection device

PARTNERSHIP

Let's Collaborate

Whether you're looking for reliable molecular testing solutions or seeking to bring your innovations from research to application, we'd be delighted to work with you.